Parabilis Medicines (PBLS) Enterprise Value: 2.678B

Parabilis Medicines, Inc. (PBLS)

30.37 +1.84 (+6.45%) USD | NASDAQ | Nov 09, 16:00

29.77 -0.60 (-1.98%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2026. Start Trial.

Date	Value
November 09, 2026	2.678B
November 06, 2026	2.451B
November 05, 2026	2.371B
November 04, 2026	2.677B
November 03, 2026	2.540B
November 02, 2026	2.293B
October 30, 2026	2.425B
October 29, 2026	2.472B
October 28, 2026	2.406B
October 27, 2026	2.201B
October 26, 2026	2.019B
October 23, 2026	1.946B
October 22, 2026	2.252B
October 21, 2026	2.367B
October 20, 2026	2.272B
October 19, 2026	2.058B
October 16, 2026	1.737B
October 15, 2026	2.037B
October 14, 2026	2.125B
October 13, 2026	2.243B
October 12, 2026	2.503B
October 09, 2026	2.321B
October 08, 2026	2.396B
October 07, 2026	2.487B
October 06, 2026	2.492B

Date	Value
October 05, 2026	2.574B
October 02, 2026	2.667B
October 01, 2026	2.687B
September 30, 2026	2.915B
September 29, 2026	2.868B
September 28, 2026	2.950B
September 25, 2026	2.781B
September 24, 2026	2.938B
September 23, 2026	3.041B
September 22, 2026	3.642B
September 21, 2026	3.488B
September 18, 2026	4.081B
September 17, 2026	3.976B
September 16, 2026	3.482B
September 15, 2026	3.339B
September 14, 2026	3.393B
September 11, 2026	3.482B
September 10, 2026	3.413B
September 09, 2026	3.714B
September 08, 2026	3.839B
September 04, 2026	3.919B
September 03, 2026	3.960B
September 02, 2026	3.881B
September 01, 2026	3.802B
August 31, 2026	3.745B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks